kapruvia
vifor fresenius medical care renal pharma france - difelikefalin - pruritus - kaikki muut terapeuttiset tuotteet - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.
ferinject 50 mg fe / ml injektio-/infuusioneste, liuos
vifor france - tehtävä carboxymaltosum - injektio-/infuusioneste, liuos - 50 mg fe / ml - rauta, parenteraaliset valmisteet
elvanse 30 mg kapseli, kova
takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 30 mg - lisdeksamfetamiini
elvanse 50 mg kapseli, kova
takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 50 mg - lisdeksamfetamiini
elvanse 70 mg kapseli, kova
takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 70 mg - lisdeksamfetamiini
elvanse 20 mg kapseli, kova
takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 20 mg - lisdeksamfetamiini
elvanse 40 mg kapseli, kova
takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 40 mg - lisdeksamfetamiini
elvanse 60 mg kapseli, kova
takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 60 mg - lisdeksamfetamiini
phenoleptil vet 25 mg tabletti
dechra regulatory b.v. - phenobarbital - tabletti - 25 mg - fenobarbitaali
phenoleptil vet 100 mg tabletti
dechra regulatory b.v. - phenobarbital - tabletti - 100 mg - fenobarbitaali